Skip to content

Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

A Double-Blind, Randomized, Placebo-Controlled Trial of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07479394
Enrollment
60
Registered
2026-03-18
Start date
2026-08-15
Completion date
2027-02-28
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Tract Infections (RTI)

Keywords

AHCC, Lentinula edodes mycelia, prebiotic, respiratory tract infection (RTI)

Brief summary

This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.

Detailed description

A three-month, randomized, double-blind, placebo-controlled, pilot study will be performed in Indonesian healthy children aged 4 to 6 years in Nursery Schools. Subjects will be administered dextrin alone (placebo) or dextrin including AHCC. The incidence of RTI will be the primary outcome, and changes in serum Interferon Gamma (IFN-γ) as the crucial cytokine that acts as anti infective in the immune system will be the secondary outcome. Following completion of the 3 months intervention, participants will enter a 5 months follow up period (Months 4-8). New onset adverse events, ongoing adverse events, serious adverse events, and investigator assessed intervention related adverse events will be collected and evaluated.

Interventions

DIETARY_SUPPLEMENTa prebiotic, that us a standardized extract of cultured Lentinula edodes mycelia

Subjects will be administered dextrin including AHCC.

DIETARY_SUPPLEMENTPlacebo (dextrin)

Subjects will be administered dextrin alone (placebo)

Sponsors

Hasanuddin University
Lead SponsorOTHER
Amino Up Co. Ltd., Sapporo, Japan
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

A three-month, randomized, double-blind, placebo-controlled, pilot study will be performed in Indonesian healthy children aged 4 to 6 years in Nursery Schools. Children will be monitored for adverse events for 5 months following completion of the 3 months intervention

Eligibility

Sex/Gender
ALL
Age
4 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

1. Children aged 4-6 years old at the time of enrolment 2. Good nutritional status with weight-for-height \> -2, and height-for-age z-score \> -2 based on WHO growth standards 3. Infants in a group setting (daycare centers). 4. No congenital disorder 5. Not suffering from severe coughing or diarrhoea at the time of recruitment 6. Written informed consent will be obtained from parents or legal guardians before enrollment.

Exclusion criteria

* Presence of chronic illnesses or conditions (congenital disorder, genetic syndromes, congenital heart disease, chronic renal failure, cystic fibrosis, etc) * Children who have participated in another clinical intervention study within the past 30 days. * Children who are likely to be transferred to another facility that is not part of the study before completing the follow-up period

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Respiratory Tract Infection3 monthsthe number incidence of infections, specifically respiratory tract infection, by looking at the number of febrile days (\>37.5 ◦C) during the test period.

Secondary

MeasureTime frameDescription
additional immunological effects3 monthsimmunomodulatory effects of AHCC, we will be checking serum IFN-γ as a biomarker of immunity at baseline and 3 months after AHCC using enzyme-linked immunosorbent assay (ELISA).
additional nutritional effect- WAZ score3 monthschanges in weight-for-age z-score as sign of growth and nutritional status.
additional nutritional effect- Weight in gram3 monthschanges in weight in gram as sign of growth and nutritional status.
additional nutritional effect- HAZ score3 monthschanges in height-for-age z-score as sign of growth and nutritional status.
additional nutritional effect- Height in cm3 monthschanges in height in cm as sign of growth and nutritional status.
additional nutritional effect- WHZ score3 monthschanges in weight-for-height z-score as sign of growth and nutritional status.
additional nutritional effect- Head circumference in cm3 monthschanges in head circumference in cm as sign of growth and nutritional status.

Contacts

CONTACTConny Tanjung, MD,PhD;Consultant Pediatrician
conny.tanj@gmail.com+6281282733388

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026